Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Genius Sports Limited’s stock clocked out at $9.40, up 0.11% from its previous closing price of $9.39. In other words, the price has increased by $0.11 from its previous closing price. On the day, 2.12 million shares were traded. GENI stock price reached its highest trading level at $9.78 during the session, while it also had its lowest trading level at $9.16.
Ratios:
To gain a deeper understanding of GENI’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.98. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 16, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $7.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Stevens Eric bought 79,373 shares for $9.38 per share.
Davison Jack bought 100,388 shares of GENI for $876,939 on Jan 17 ’25. On Jan 10 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 8,202 shares for $8.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2150437888 and an Enterprise Value of 1866210432. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.55 while its Price-to-Book (P/B) ratio in mrq is 3.47. Its current Enterprise Value per Revenue stands at 3.653 whereas that against EBITDA is 114.625.
Stock Price History:
The Beta on a monthly basis for GENI is 2.01, which has changed by 0.60683763 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $10.33, while it has fallen to a 52-week low of $4.91. The 50-Day Moving Average of the stock is 4.13%, while the 200-Day Moving Average is calculated to be 22.39%.
Shares Statistics:
It appears that GENI traded 2.49M shares on average per day over the past three months and 4457110 shares per day over the past ten days. A total of 211.16M shares are outstanding, with a floating share count of 206.12M. Insiders hold about 9.90% of the company’s shares, while institutions hold 80.31% stake in the company. Shares short for GENI as of 1740700800 were 30922498 with a Short Ratio of 12.41, compared to 1738281600 on 29680139. Therefore, it implies a Short% of Shares Outstanding of 30922498 and a Short% of Float of 17.919999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
